eFFECTOR Therapeutics, Inc.
EFTR · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,834 | -$9,129 | -$8,303 | -$8,364 |
| Dep. & Amort. | $28 | $30 | $26 | $27 |
| Deferred Tax | $0 | $63 | -$175 | -$78 |
| Stock-Based Comp. | $1,010 | $1,124 | $1,142 | $1,162 |
| Change in WC | $479 | $2,428 | -$521 | -$1,432 |
| Other Non-Cash | $39 | -$82 | $76 | $93 |
| Operating Cash Flow | -$7,278 | -$5,566 | -$7,755 | -$8,592 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$54 | -$2 | -$28 |
| Net Acquisitions | $0 | $0 | $1,913 | $1,546 |
| Inv. Purchases | -$9,821 | $0 | -$3,913 | -$10,296 |
| Inv. Sales/Matur. | $3,500 | $9,000 | $2,000 | $8,750 |
| Other Inv. Act. | $0 | $0 | -$1,913 | -$1,546 |
| Investing Cash Flow | -$6,321 | $8,946 | -$1,915 | -$1,574 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$556 | $0 | $0 | $0 |
| Stock Issued | $14,787 | $6,109 | $324 | $14,532 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $0 | $18 | $38 |
| Financing Cash Flow | $14,232 | $6,109 | $342 | $14,570 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $633 | $9,489 | -$9,328 | $4,404 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,875 | $5,386 | $14,714 | $10,310 |
| End Cash | $15,508 | $14,875 | $5,386 | $14,714 |
| Free Cash Flow | -$7,278 | -$5,620 | -$7,757 | -$8,620 |